Joel Goldstein

Person

Piscataway, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Agonistic antibodies that bind human CD40 and uses thereof
- Patent number 12,297,266
- Issue date May 13, 2025
- Celldex Therapeutics, Inc.
- Tibor Keler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD27 and anti-PD-L1 antibodies and bispecific constructs
- Patent number 11,459,393
- Issue date Oct 4, 2022
- Celldex Therapeutics, Inc.
- Tibor Keler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD27 and anti-PD-L1 antibodies and bispecific constructs
- Patent number 11,332,537
- Issue date May 17, 2022
- Celldex Therapeutics, Inc.
- Tibor Keler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of inducing or enhancing an immune response comprising admi...
- Patent number 10,941,201
- Issue date Mar 9, 2021
- Celldex Therapeutics, Inc.
- Tibor Keler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acids encoding agonistic antibodies that bind CD40
- Patent number 10,865,244
- Issue date Dec 15, 2020
- Celldex Therapeutics, Inc.
- Tibor Keler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Agonistic antibodies that bind CD40
- Patent number 10,633,444
- Issue date Apr 28, 2020
- Celldex Therapeutics, Inc.
- Tibor Keler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cells expressing anti-Fc receptor binding components
- Patent number 7,316,812
- Issue date Jan 8, 2008
- Celldex Therapeutics, Inc.
- Tibor Keler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cells expressing anti-Fc receptor binding components
- Patent number 6,682,928
- Issue date Jan 27, 2004
- Medarex, Inc.
- Tibor Keler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic compounds comprised of anti-Fc receptor antibodies
- Patent number 6,410,690
- Issue date Jun 25, 2002
- Medarex, Inc.
- Yashwant M. Deo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic compounds comprised of anti-Fc receptor antibodies
- Patent number 6,395,272
- Issue date May 28, 2002
- Mederex, Inc.
- Yashwant M. Deo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic compounds comprised of anti-FC receptor binding agents
- Patent number 6,365,161
- Issue date Apr 2, 2002
- Medarex, Inc.
- Yashwant M. Deo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic compounds comprised of anti-Fc receptor antibodies
- Patent number 6,270,765
- Issue date Aug 7, 2001
- Medarex, Inc.
- Yashwant M. Deo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic compounds comprised of anti-Fc receptor antibodies
- Patent number 5,837,243
- Issue date Nov 17, 1998
- Medarex, Inc.
- Yashwant M. Deo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
AGONISTIC ANTIBODIES THAT BIND CD40
- Publication number 20250115663
- Publication date Apr 10, 2025
- CELLDEX THERAPEUTICS, INC.
- Tibor KELER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD27 AGONISTS
- Publication number 20250059291
- Publication date Feb 20, 2025
- CELLDEX THERAPEUTICS, INC.
- Tibor KELER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST ILT4, BISPECIFIC ANTI-ILT4/PD-L1 ANTIBODY AND US...
- Publication number 20240417459
- Publication date Dec 19, 2024
- CELLDEX THERAPEUTICS, INC.
- Tibor KELER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-ILT4 AND ANTI-PD-1 BISPECIFIC CONSTRUCTS
- Publication number 20240409639
- Publication date Dec 12, 2024
- CELLDEX THERAPEUTICS, INC.
- Tibor KELER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-KIT ANTIBODIES AND USES THEREOF
- Publication number 20240117057
- Publication date Apr 11, 2024
- CELLDEX THERAPEUTICS, INC.
- Joel Goldstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CHRONIC PRURIGO
- Publication number 20240109961
- Publication date Apr 4, 2024
- CELLDEX THERAPEUTICS, INC.
- Bret Alan Holley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD27 AND ANTI-PD-L1 ANTIBODIES AND BISPECIFIC CONSTRUCTS
- Publication number 20220324990
- Publication date Oct 13, 2022
- CELLDEX THERAPEUTICS, INC.
- Tibor KELER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-AXL ANTIBODIES AND METHODS OF USE THEREOF
- Publication number 20220177593
- Publication date Jun 9, 2022
- CELLDEX THERAPEUTICS, INC.
- Tibor Keler
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD27 AND ANTI-PD-L1 ANTIBODIES AND BISPECIFIC CONSTRUCTS
- Publication number 20220025063
- Publication date Jan 27, 2022
- CELLDEX THERAPEUTICS, INC.
- Tibor KELER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD27 AND ANTI-PD-L1 ANTIBODIES AND BISPECIFIC CONSTRUCTS
- Publication number 20210198374
- Publication date Jul 1, 2021
- CELLDEX THERAPEUTICS, INC.
- Tibor KELER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AGONISTIC ANTIBODIES THAT BIND CD40
- Publication number 20210147538
- Publication date May 20, 2021
- CELLDEX THERAPEUTICS, INC.
- Tibor KELER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AGONISTIC ANTIBODIES THAT BIND HUMAN CD40 AND USES THEREOF
- Publication number 20200377606
- Publication date Dec 3, 2020
- CELLDEX THERAPEUTICS, INC.
- Tibor KELER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AGONISTIC ANTIBODIES THAT BIND HUMAN CD40 AND USES THEREOF
- Publication number 20200369768
- Publication date Nov 26, 2020
- CELLDEX THERAPEUTICS, INC.
- Tibor KELER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD27 AND ANTI-PD-L1 ANTIBODIES AND BISPECIFIC CONSTRUCTS
- Publication number 20200109207
- Publication date Apr 9, 2020
- CELLDEX THERAPEUTICS, INC.
- Tibor KELER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AGONISTIC ANTIBODIES THAT BIND HUMAN CD40 AND USES THEREOF
- Publication number 20190322743
- Publication date Oct 24, 2019
- CELLDEX THERAPEUTICS, INC.
- Tibor KELER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AGONISTIC ANTIBODIES THAT BIND HUMAN CD40 AND USES THEREOF
- Publication number 20180066053
- Publication date Mar 8, 2018
- CELLDEX THERAPEUTICS, INC.
- Tibor KELER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CD27 AGONISTS
- Publication number 20180044429
- Publication date Feb 15, 2018
- CELLDEX THERAPEUTICS, INC.
- Tibor KELER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Cells expressing anti-Fc receptor binding components
- Publication number 20050142120
- Publication date Jun 30, 2005
- Tibor Keler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CELLS EXPRESSING ANTI-FC RECEPTOR BINDING COMPONENTS
- Publication number 20030039641
- Publication date Feb 27, 2003
- TIBOR KELER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Recombinant cat allergen, Fel dI, expressed in baculovirus for diag...
- Publication number 20020164342
- Publication date Nov 7, 2002
- Paul M. Guyre
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTIC COMPOUNDS COMPRISED OF ANTI-FC RECEPTOR ANTIBODIES
- Publication number 20020032312
- Publication date Mar 14, 2002
- Medarex, Inc.
- YASHWANT M. DEO
- C07 - ORGANIC CHEMISTRY

Joel Goldstein

Person

Patents Grantslast 30 patents

Agonistic antibodies that bind human CD40 and uses thereof

Anti-CD27 and anti-PD-L1 antibodies and bispecific constructs

Anti-CD27 and anti-PD-L1 antibodies and bispecific constructs

Methods of inducing or enhancing an immune response comprising admi...

Nucleic acids encoding agonistic antibodies that bind CD40

Agonistic antibodies that bind CD40

Cells expressing anti-Fc receptor binding components

Cells expressing anti-Fc receptor binding components

Therapeutic compounds comprised of anti-Fc receptor antibodies

Therapeutic compounds comprised of anti-Fc receptor antibodies

Therapeutic compounds comprised of anti-FC receptor binding agents

Therapeutic compounds comprised of anti-Fc receptor antibodies

Therapeutic compounds comprised of anti-Fc receptor antibodies

Patents Applicationslast 30 patents

AGONISTIC ANTIBODIES THAT BIND CD40

CD27 AGONISTS

ANTIBODIES AGAINST ILT4, BISPECIFIC ANTI-ILT4/PD-L1 ANTIBODY AND US...

ANTI-ILT4 AND ANTI-PD-1 BISPECIFIC CONSTRUCTS

ANTI-KIT ANTIBODIES AND USES THEREOF

TREATMENT OF CHRONIC PRURIGO

ANTI-CD27 AND ANTI-PD-L1 ANTIBODIES AND BISPECIFIC CONSTRUCTS

ANTI-AXL ANTIBODIES AND METHODS OF USE THEREOF

ANTI-CD27 AND ANTI-PD-L1 ANTIBODIES AND BISPECIFIC CONSTRUCTS

ANTI-CD27 AND ANTI-PD-L1 ANTIBODIES AND BISPECIFIC CONSTRUCTS

AGONISTIC ANTIBODIES THAT BIND CD40

AGONISTIC ANTIBODIES THAT BIND HUMAN CD40 AND USES THEREOF

AGONISTIC ANTIBODIES THAT BIND HUMAN CD40 AND USES THEREOF

ANTI-CD27 AND ANTI-PD-L1 ANTIBODIES AND BISPECIFIC CONSTRUCTS

AGONISTIC ANTIBODIES THAT BIND HUMAN CD40 AND USES THEREOF

AGONISTIC ANTIBODIES THAT BIND HUMAN CD40 AND USES THEREOF

CD27 AGONISTS

Cells expressing anti-Fc receptor binding components

CELLS EXPRESSING ANTI-FC RECEPTOR BINDING COMPONENTS

Recombinant cat allergen, Fel dI, expressed in baculovirus for diag...

THERAPEUTIC COMPOUNDS COMPRISED OF ANTI-FC RECEPTOR ANTIBODIES